Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • DBT launches Sohum -...

    DBT launches Sohum - an innovative newborn hearing screening device

    Written by Ruby Khatun Khatun Published On 2017-07-22T09:00:15+05:30  |  Updated On 22 July 2017 9:00 AM IST
    DBT launches Sohum - an innovative newborn hearing screening device

    The Honorable Minister of State, Ministry of Science and Technology & Earth Sciences, Shri Y.S. Chowdary, launched Sohum – the newborn hearing screening device developed by SIB startup M/s Sohum Innovation Labs India Pvt. Ltd. on July 17th, 2017 at Prithvi Bhavan. The indigenously developed Sohum was formally launched by the Minister in the presence of Prof. K. VijayRaghavan, Secretary DBT and other dignitaries, as a valuable contribution to the Make in India campaign of the Government.


    This innovative medical device has been developed under Department of Biotechnology (DBT), Ministry of Science and Technology; Government of India supported School of International Biodesign (SIB). SIB is a flagship Program of the DBT aimed to develop innovative and affordable medical devices as per unmet clinical needs of India and to train the next generation of medical technology innovators in India. This Program is implemented jointly at AIIMS and IIT Delhi in collaboration with International partners. Biotech Consortium India Limited manages techno-legal activities of the Program.


    Sohum is a low cost and unique device which uses brain stem auditory evoked response, the gold standard in auditory testing to check for hearing response in a newborn. As of now, this technology is prohibitively expensive and inaccessible to many. Start-up Sohum has made the technology appropriate for the resource constrained settings and aims to cater to nearly 26 million babies born every year in India.


    One of the most common birth disorders – congenital hearing loss – is a result of both genetic and non-genetic factors. These factors are mostly associated with resource-poor economies such as India where, unlike advanced healthcare systems, hearing impairment goes undiagnosed. Thus, when it is discovered at 4+ years, it’s too late to reverse the damage and this leads to a host of problems such as impaired communication skills and even possible mental illness; all of which have a deep impact on the child, emotionally and economically life-long.


    Globally, 800000 hearing impaired babies are born annually of which, nearly 100000 are in India. And all this preventable damage needs is early screening, which can facilitate timely treatment and rehabilitation. Sohum team has come up with a screening device to facilitate the routine screening of newborn babies – with the potential to help children at a key stage of their development.


    The portable Sohum Hearing Screening measures auditory brain waves via three electrodes placed on the baby’s head. When stimulated, they detect electrical responses generated by the brain’s auditory system. If there is no response, the child cannot hear. The battery-operated device is non-invasive, which means babies do not need to be sedated, which is the current, and risky, testing in process at present.


    Another key advantage over other testing systems is the patented, in-built algorithm that filters out ambient noise from the test signal. This is important because health clinics can be incredibly crowded and noisy. The device has been installed in five clinical centers, which are currently running the hearing screening program. The aim is to screen two percent of hospital-born babies in the first year, before scaling up. The project has ambitious plans – to help every baby born in India be screened.

    AIIMSbabiesBiotech Consortium India LimitedDBTDepartment of Biotechnologyhearing impairmentIIT DelhiMinistry of Science and Technologynew born screeningnewborn hearing screening deviceSchool of International BiodesignSohum
    Source : PRESS RELEASE

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok